Exome sequencing identifies novel susceptibility genes and defines the contribution of coding variants to breast cancer risk.
Wilcox, N.; Dumont, M.; Gonzalez-Neira, A.; Carvalho, S.; Beauparlant, C. J.; Crotti, M.; Luccarini, C.; Soucy, P.; Dubois, S.; Nunez-Torres, R.; Pita, G.; Alonso, M. R.; Alvarez, N.; Baynes, C.; Becker, H.; Behrens, S.; Bolla, M. K.; Castelao, J. E.; Chang-Claude, J.; Cornelissen, S.; Dennis, J.; Dörk, T.; Engel, C.; Gago-Dominguez, M.; Guenel, P.; Hadjisavvas, A.; Hahnen, E.; Hartman, M.; Herraez, B.; Investigators, S.; Jung, A.; Keeman, R.; Kiechle, M.; Li, J.; Loizidou, M. A.; Lush, M.; Michailidou, K.; Panayiotidis, M. I.; Sim, X.; Teo, S. H.; Tyrer, J. P.; van der Kolk, L. E.; Wahlstrom
Show abstract
Introductory paragraphLinkage and candidate gene studies have identified several breast cancer susceptibility genes, but the overall contribution of coding variation to breast cancer is unclear. To evaluate the role of rare coding variants more comprehensively, we performed a meta-analysis across three large whole-exome sequencing datasets, containing 16,498 cases and 182,142 controls. Burden tests were performed for protein-truncating and rare missense variants in 16,562 and 18,681 genes respectively. Associations between protein-truncating variants and breast cancer were identified for 7 genes at exome-wide significance (P<2.5x10-6): the five known susceptibility genes BRCA1, BRCA2, CHEK2, PALB2 and ATM, together with novel associations for ATRIP and MAP3K1. Predicted deleterious rare missense or protein-truncating variants were additionally associated at P<2.5x10-6 for SAMHD1. The overall contribution of coding variants in genes beyond the previously known genes is estimated to be small.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses 97%
- Genomic profiling defines variable clonal relatedness between invasive breast cancer and primary ductal carcinoma in situ 95%
- Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes 94%
Similar papers in this journal
- Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes 94%
- Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates 94%
- Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction 94%
Similar papers in this journal
- A joint transcriptome-wide association study across multiple tissues identifies new candidate susceptibility genes for breast cancer 95%
- A polygenic score-based approach to identify gene-drug interactions stratifying breast cancer risk 95%
- Segregation analysis of 17,425 population-based breast cancer families: evidence for genetic susceptibility and risk prediction 95%
Similar papers in this journal
- Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy 94%
- Towards resolution of the intron retention paradox in breast cancer 94%
- Integrative multi-omic sequencing reveals the MMTV-Myc mouse model mimics human breast cancer heterogeneity 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.